Dietary supplement for insulin-resistant diabetics

Details Dietary supplement for insulin-resistant diabetics Dietary supplement for insulin-resistant diabetics

1991-03-21

1992-06-23

Ivy, C. Warren

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

514866, A61K 31045

Patent

active

051243601

ABSTRACT:
A dietary supplement for the therapeutic treatment of those exhibiting clinical symptoms of insulin-resistant type II diabetes, and preventing the development of clinical symptoms in those genetically predisposed to the development of such symptoms, is provided by the administration of a dietary supplement comprising D-chiro-inositol. The dietary supplement is preferably administered orally, in vitamin-like amounts.

REFERENCES:
Holub, B., "The Nutritional Significance . . . ", Adv. Nutr. Res. 4 107-141 (1982).
Schweizer et al., "Low Molecular . . . ", J. Sci. Agric. 29 148-154 (1978).
Phillips et al., "Cyclitols in Soybean", J. Agric. Food. Chem. 30 456-458 (1982).
Wober et al., "Untersuchungen . . . ", Monatshefte fur Chemie 102 459-464 (1971).
Price et al., "Effect of Aldose Reductase . . . ", CA: 109, 71448 (1988).
Knudsen et al., "Myo-Inositol Normalizes Decreased . . . ", CA: 110, 50387 (1989).
Merck Index pp. 722-723, Compound #4861.

Affiliated with

Also associated with

Rating

Dietary supplement for insulin-resistant diabetics does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dietary supplement for insulin-resistant diabetics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary supplement for insulin-resistant diabetics will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-933157